Cancer Res. 1986 Apr;46(4 Pt 2):2068-71.

Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

Shipley GD, Pittelkow MR, Wille JJ Jr, Scott RE, Moses HL.

Abstract

Type beta transforming growth factor-growth inhibitor (TGF beta/GI) causes normal human prokeratinocytes to arrest growth predominantly in the G1 phase of the cell cycle within 48 h after log phase cultures are exposed to the factor in serum-free medium. The growth arrest induced by TGF beta/GI is reversible because the cells from treated cultures can be replated into fresh medium and grown into large colonies. Normal prokeratinocytes are demonstrated to secrete TGF beta/GI-like molecules into the culture medium and to have specific cell surface receptors for this molecule. In contrast, a human squamous cell carcinoma, SCC-25, does not arrest growth when exposed to TGF beta/GI. These cells, unlike the normal prokeratinocytes, do not exhibit detectable cell surface receptors for the factor.

PMID:: 2418960; [PubMed - indexed for MEDLINE]

Free full text

LinkOut - more resources

Full Text Sources

HighWire Press

Supplemental Content

Save items

Related citations in PubMed

Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines. [Cancer Res. 1989]
Lack of correlation between sensitivity to growth inhibition and receptor number for transforming growth factor beta in human squamous carcinoma cell lines.
Hébert CD, Birnbaum LS. Cancer Res. 1989 Jun 15; 49(12):3196-202.
Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta. [J Cell Physiol. 1989]
Environment-dependent growth inhibition of human epidermal keratinocytes by recombinant human transforming growth factor-beta.
Rollins BJ, O'Connell TM, Bennett G, Burton LE, Stiles CD, Rheinwald JG. J Cell Physiol. 1989 Jun; 139(3):455-62.
Two subtypes of reversible cell cycle restriction points exist in cultured normal human keratinocyte progenitor cells. [Lab Invest. 1988]
Two subtypes of reversible cell cycle restriction points exist in cultured normal human keratinocyte progenitor cells.
Wilke MS, Hsu BM, Scott RE. Lab Invest. 1988 Jun; 58(6):660-6.
Review Transforming growth factor beta in the control of epidermal proliferation. [Am J Med Sci. 1988]
Review Transforming growth factor beta in the control of epidermal proliferation.
Barnard JA, Bascom CC, Lyons RM, Sipes NJ, Moses HL. Am J Med Sci. 1988 Sep; 296(3):159-63.
Review Transforming growth factor beta regulation of cell proliferation. [J Cell Physiol Suppl. 1987]
Review Transforming growth factor beta regulation of cell proliferation.
Moses HL, Coffey RJ Jr, Leof EB, Lyons RM, Keski-Oja J. J Cell Physiol Suppl. 1987; Suppl 5:1-7.

See reviews... See all...

Cited by 62 PubMed Central articles

Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2). [FASEB J. 2011]
Transcriptional and post-translational regulation of the quiescence factor and putative tumor suppressor p150(Sal2).
Sung CK, Dahl J, Yim H, Rodig S, Benjamin TL. FASEB J. 2011 Apr; 25(4):1275-83. Epub 2011 Jan 12.
Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes. [Mol Biol Cell. 2010]
Receptor type protein tyrosine phosphatase-kappa mediates cross-talk between transforming growth factor-beta and epidermal growth factor receptor signaling pathways in human keratinocytes.
Xu Y, Baker D, Quan T, Baldassare JJ, Voorhees JJ, Fisher GJ. Mol Biol Cell. 2010 Jan 1; 21(1):29-35. Epub 2009 Oct 28.
Expression, localisation and functional activation of NFAT-2 in normal human skin, psoriasis, and cultured keratocytes. [Int J Clin Exp Med. 2009]
Expression, localisation and functional activation of NFAT-2 in normal human skin, psoriasis, and cultured keratocytes.
Al-Daraji WI, Malak TT, Prescott RJ, Abdellaoui A, Ali MM, Dabash T, Zelger BG, Zelger B. Int J Clin Exp Med. 2009 Jun 18; 2(2):176-92. Epub 2009 Jun 18.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Reversible inhibition of normal human prokeratinocyte proliferation by type beta...
Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.
Cancer Res. 1986 Apr ;46(4 Pt 2):2068-71.

PubMed
Oxygen-dependent microbial killing by phagocytes (first of two parts).
Oxygen-dependent microbial killing by phagocytes (first of two parts).
N Engl J Med. 1978 Mar 23 ;298(12):659-68.

PubMed
Clinical applications of antiviral agents for chemophrophylaxis and therapy of r...
Clinical applications of antiviral agents for chemophrophylaxis and therapy of respiratory viral infections.
Antiviral Res. 1985 ;Suppl 1:229-39.

PubMed
The Cardiac Arrhythmia Pilot Study. The CAPS investigators.
The Cardiac Arrhythmia Pilot Study. The CAPS investigators.
Am J Cardiol. 1986 Jan 1 ;57(1):91-5.

PubMed
Child psychiatric sequelae of maternal war stress.
Child psychiatric sequelae of maternal war stress.
Acta Psychiatr Scand. 1985 Dec ;72(6):505-11.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium.

Abstract

Publication Types, MeSH Terms, Substances, Grant Support

Publication Types

MeSH Terms

Substances

Grant Support

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Cited by 62 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information